-6.65 (-1.66%)
-6.05 (-1.52%) 3.59 pm | 12 Mar 2012 | Source: CNBC-TV18
In an interview with CNBC-TV18, Bhaskar Narayana, finance director & CFO of Natco Pharma spoke about the judgment where the company is granted compul...
3.12 pm | 12 Mar 2012 | Source: Moneycontrol.com
In a landmark judgement by India's Patent Office, Natco Pharma has won a compulsory license from Bayer for patent protected anti-cancer drug Nexavar, ...